Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML. (December 2016) - Tontsch-Grunt, U.; Savarese, F.; Baum, A.; Scharn, D.; Gerlach, D.; Hofmann, M.H.; Popow, J.; Schweifer, N.; Engelhardt, H.; Musa, H.; Lee, C.P.; Munzert, G.M.; et al.